Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent (DECLARELONG)

This study has been completed.
Otsuka Korea
Information provided by:
CardioVascular Research Foundation, Korea Identifier:
First received: December 31, 2007
Last updated: March 17, 2010
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)